Apogee Therapeutics, Inc. · NASDAQ:APGE
Fairmount Healthcare Fund II L.P. exercised options for 42,208 Apogee Therapeutics, Inc. shares (Form 4)
Traded Aug 7, 2026 · Filed Aug 11, 2026
On Aug 7, 2026, Fairmount Healthcare Fund II L.P. (Director) exercised options for 42,208 Apogee Therapeutics, Inc. shares at an average US$23.60 for US$996K, leaving 340,855 shares. Filed Aug 11, 2026 (Form 4).
- Options exercised
- 42,208 shares
- Price
- US$23.60 average (US$17.00 to US$43.85)
- Value
- US$996K
- Holding after
- 340,855 shares (held indirectly)
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Aug 7, 2026 | Common Stock | Option exercise | 31,838 | US$17.00 | 330,485 | Indirect |
| Aug 7, 2026 | Common Stock | Option exercise | 10,370 | US$43.85 | 340,855 | Indirect |
Source
Related
- Apogee Therapeutics, Inc.
- Fairmount Healthcare Fund II L.P.
- Apogee Therapeutics, Inc. shareholders
- Schedule 13D/A · Venrock Healthcare Capital Partners III, L.P. · Sep 8, 2026
- Form 4 · Fairmount Funds Management LLC · Sep 3, 2026
- Form 4 · McKenna Mark C. · Sep 3, 2026
- Form 4 · Jones William A Jr · Sep 3, 2026
- Form 4 · Dambkowski Carl · Sep 3, 2026